Well I did say it was an unknown amount because it hasn't been released, so no I have not got the details. My main point was that it won't be MSB's 100%. In my view Osiris struggled with the aGvHD treatment in NZ and Canada gaining approval for its use only in children whose disease can not be controlled with steroids, and missing end points for adults. They then found sales tough in both NZ and Canada and for these reasons amongst others including being unhappy with their phamaceutical partnership sold the whole sales deal with JCR and the associated suite of ip to MSB.
Well I did say it was an unknown amount because it hasn't been...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |